Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:
- a blog post indicating a recent Federal Circuit opinion provided a “fascinating exploration of three distinct doctrines of equivalence in patent law”;
- another blog post suggesting the USPTO sits “at an inflection point that requires us to build examination capacity to achieve . . . long-term pendency goals”;
- an article discussing how President Trump’s decisions to mandate “a hiring freeze across the federal government” and require “federal government employees come back to the Office five days per week” might impact the USPTO; and
- a news update analyzing how the “Skinny Labels, Big Savings Act, introduced at the end of last year and reintroduced this month in the new Congress,” is seeking to “protect generic-drug makers from patent suits when using so-called skinny labels.”